Autoantibodies (aAb) associated with Alzheimer’s disease (AD) have not been sufficiently characterized and their exact involvement is undefined. The use of information technology and computerized analysis with phage display technology was used, in the present research, to map the epitope of putative self-antigens in AD patients. A 12-mer random peptide library, displayed on M13 phages, was screened using IgG from AD patients with two repetitions. Seventy-one peptides were isolated; however, only 10 were positive using the Elisa assay technique (Elisa Index > 1). The results showed that the epitope regions of the immunoreactive peptides, identified by phage display analysis, were on the exposed surfaces of the proteins. The putative antigens...
Objectives - To detect the reactivity pattern of sera from patients with mild and severe Alzheimer's...
Antibodies are a class of proteins that are made by the immune system to recognize harmful organisms...
Objectives - To detect the reactivity pattern of sera from patients with mild and severe Alzheimer's...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The characterization of the humoral response in Alzheimer’s disease (AD) patients might aid in detec...
Alzheimer's Disease (AD) is the most important cause of dementia in the world.The involvement of the...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
After decades of Alzheimer's disease (AD) research, the development of a definitive diagnostic test ...
Amyloid plaques (AP) represent one of the main molecular hallmarks of Alzheimer's disease (AD). In o...
Autoantigenic epitope mapping represents a critical issue in autoimmune diseases. The islet tyrosine...
Autoantigenic epitope mapping represents a critical issue in autoimmune diseases. The islet tyrosine...
Autoantigenic epitope mapping represents a critical issue in autoimmune diseases. The islet tyrosine...
Objectives - To detect the reactivity pattern of sera from patients with mild and severe Alzheimer's...
Antibodies are a class of proteins that are made by the immune system to recognize harmful organisms...
Objectives - To detect the reactivity pattern of sera from patients with mild and severe Alzheimer's...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The characterization of the humoral response in Alzheimer’s disease (AD) patients might aid in detec...
Alzheimer's Disease (AD) is the most important cause of dementia in the world.The involvement of the...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder frequently diagnosed among the ...
After decades of Alzheimer's disease (AD) research, the development of a definitive diagnostic test ...
Amyloid plaques (AP) represent one of the main molecular hallmarks of Alzheimer's disease (AD). In o...
Autoantigenic epitope mapping represents a critical issue in autoimmune diseases. The islet tyrosine...
Autoantigenic epitope mapping represents a critical issue in autoimmune diseases. The islet tyrosine...
Autoantigenic epitope mapping represents a critical issue in autoimmune diseases. The islet tyrosine...
Objectives - To detect the reactivity pattern of sera from patients with mild and severe Alzheimer's...
Antibodies are a class of proteins that are made by the immune system to recognize harmful organisms...
Objectives - To detect the reactivity pattern of sera from patients with mild and severe Alzheimer's...